Concepedia

Patrick P. Zarrinkar

PP

32

Publications

12.5K

Citations

25

H-Index

1991

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Kura Oncology (United States)

Wellspring Biosciences (United States)

Genomics Institute of the Novartis Research Foundation

Johns Hopkins University

Patrick P. Zarrinkar is an author at Massachusetts Institute of Technology specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicineDrug DiscoveryNatural SciencesBiochemistryPharmacologyMolecular BiologySystems BiologyCell BiologyTumor BiologyRadiation Oncology

Publications per year

1991–2018

32

Publications

32

A quantitative analysis of kinase inhibitor selectivity

Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations

Drug Target, Signal Transduction, Medicine +6

Comprehensive analysis of kinase inhibitor selectivity

Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård et al. · Nature Biotechnology · 2011 · 2.3K citations · Full text

Drug Target, Signal Transduction, Medicine +5

A small molecule–kinase interaction map for clinical kinase inhibitors

Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text

Molecular Docking, Drug Target, Clinical Kinase Inhibitors +4

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li et al. · Cell · 2018 · 1.1K citations · Full text

Kras Mutant Cancers, Medicine, Anti-cancer Agent +6

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

Catherine C. Smith, Qi Wang, Chen-Shan Chin et al. · Nature · 2012 · 734 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Rows per page

1–5 of 32